News

Filter

Current filters:

Cialis

1 to 9 of 165 results

Eli Lilly exceeds expectations with third quarter results

Eli Lilly exceeds expectations with third quarter results

24-10-2013

US pharma major Eli Lilly has announced financial results for the third quarter of 2013. Despite the…

AlimtaAmyvidAxironCialisCymbaltaEffientEli LillyEvistaFinancialForteoHumalogNorth AmericaPharmaceuticalStratteraTrajentaZyprexa

Eli Lilly records higher than expected earnings in 2nd-qtr results

24-07-2013

US drug major Eli Lilly's (NYSE: LLY) recorded higher than expected earnings as growth in key products…

AlimtaCialisCymbaltaEffientEli LillyEvistaFinancialForteoHumalogNorth AmericaPharmaceuticalStratteraZyprexa

Lilly's ED drug Cialis meets endpoint in LUTS/BPH study

19-03-2013

US drug major Eli Lilly (NYSE: LLY) presented results yester day at the annual European Association of…

CialisEli LillyGenito-urinaryMen's HealthPharmaceuticalResearch

Study finds "Big Pharma" fails at self-policing ED drug advertising

18-02-2013

The pharmaceutical industry's efforts to self-regulate its direct-to-consumer (DTC) advertising are "an…

BayerCialisEli LillyLevitraMarkets & MarketingMen's HealthPfizerPharmaceuticalRegulationViagra

European Commission approves Lilly's Cialis for BPH

31-10-2012

The European Commission has approved US drug major Eli Lilly's (NYSE: LLY) Cialis (tadalafil), 5mg for…

CialisEli LillyEuropeMen's HealthPharmaceuticalRegulation

Fake erectile dysfunction drugs seized in joint international raids

21-03-2012

In a joint operation, known as Operation Tribulus, led by Spanish police and coordinated by Europol,…

CialisEuropeLevitraMarkets & MarketingMen's HealthPharmaceuticalRegulationViagra

1 to 9 of 165 results

COMPANY SPOTLIGHT

Menarini

Back to top